Brian Mehling, MD, and Michael Kelly, MD had a successful presentation at the Princess Grace Hospital Monaco in Monte Carlo, France.
Dr. Brian Mehling’s presentation was focused on BHI Therapeutic Sciences (BHITS) stem cell research studies.
It included BHITS stem cell therapy methods, results of Institutional Review Board approved stem cell research studies, resent advances in BHITS stem cell research (Presentation at the American Academy of Orthopedic Surgeons Annual Meeting, New Orleans, Louisiana, 2018 and Presentation at the conference Adult Stem Cells and Regenerative Medicine. The New York Academy of Sciences, NY, 2019) and information on FDA endorsed Investigational New Drug (IND) application entitled Evaluation of the Safety and Efficacy of HPC, Cord Blood in Subjects With Acute Ischemic Stroke.
Dr. Michael Kelly’s presentation was specifically focused on BHITS follow-on IND application entitled “Evaluation of the Safety and Efficacy of Hematopoietic Progenitor Cells, Cord Blood in Subjects with Knee Osteoarthritis Associated Pain”.
It described the study objectives, inclusion and exclusion criteria, safety and efficacy endpoints.
Leave a Reply